Exosome Mediated Cancer Therapeutic Approach:Present Status and Future Prospectives
- PMID: 36853283
- PMCID: PMC10162618
- DOI: 10.31557/APJCP.2023.24.2.363
Exosome Mediated Cancer Therapeutic Approach:Present Status and Future Prospectives
Abstract
The unique extracellular vesicles (EVs) or exosomes formed by the sequential invagination of the plasma membrane are diverse and encompass important constituents with biological functions. Speculations on its cell independent biological functions are significant and pose them as vital biomarkers and as drug delivery vehicles especially in cancer. EVs possess theragnostic values and are known to elicit specific immune response. Exosomes can also serve as potential nanocarriers for delivering miRNA, siRNA, anti-cancer drugs and membrane-associated proteins. Exosomes play a crucial role in regulating tumour progression, metastasis, and angiogenesis. This review thus portrays the multiple facets of exosomes, in concert with the source for exosomes production and further on its regulation and intercellular communication. The review also explores the recent advances, present status and the future prospective in the application of exosomes in cancer therapeutics and cancer diagnostics.
Keywords: cancer-therapeutics; drug delivery vehicles; exosomes; immuno-therapy.
Conflict of interest statement
The authors declare that there is no conflict of interest.
Figures
![Figure 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a69/10162618/3137eafe66e6/APJCP-24-363-g001.gif)
![Figure 2](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a69/10162618/369f60cb4293/APJCP-24-363-g002.gif)
Similar articles
-
The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].Cell Oncol (Dordr). 2018 Jun;41(3):223-252. doi: 10.1007/s13402-018-0378-4. Epub 2018 Apr 17. Cell Oncol (Dordr). 2018. PMID: 29667069 Review.
-
Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications.Cell Commun Signal. 2019 Jul 10;17(1):73. doi: 10.1186/s12964-019-0390-y. Cell Commun Signal. 2019. PMID: 31291956 Free PMC article. Review.
-
Exosome-Based Smart Drug Delivery Tool for Cancer Theranostics.ACS Biomater Sci Eng. 2023 Feb 13;9(2):577-594. doi: 10.1021/acsbiomaterials.2c01329. Epub 2023 Jan 9. ACS Biomater Sci Eng. 2023. PMID: 36621949 Free PMC article. Review.
-
Organically derived exosomes as carriers of anticancer drugs and imaging agents for cancer treatment.Semin Cancer Biol. 2022 Nov;86(Pt 1):80-100. doi: 10.1016/j.semcancer.2022.02.020. Epub 2022 Feb 19. Semin Cancer Biol. 2022. PMID: 35192929 Free PMC article. Review.
-
The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma.Oncotarget. 2017 Jan 10;8(2):3683-3695. doi: 10.18632/oncotarget.12465. Oncotarget. 2017. PMID: 27713136 Free PMC article. Review.
Cited by
-
A comprehensive overview of exosome lncRNAs: emerging biomarkers and potential therapeutics in endometriosis.Front Endocrinol (Lausanne). 2023 Jun 26;14:1199569. doi: 10.3389/fendo.2023.1199569. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37455911 Free PMC article. Review.
-
The biological roles of CD47 in ovarian cancer progression.Cancer Immunol Immunother. 2024 Jun 4;73(8):145. doi: 10.1007/s00262-024-03708-3. Cancer Immunol Immunother. 2024. PMID: 38832992 Free PMC article. Review.
-
Tumorigenic and tumoricidal properties of exosomes in cancers; a forward look.Cell Commun Signal. 2024 Feb 15;22(1):130. doi: 10.1186/s12964-024-01510-3. Cell Commun Signal. 2024. PMID: 38360641 Free PMC article. Review.
-
Therapeutic combinations of exosomes alongside cancer stem cells (CSCs) and of CSC-derived exosomes (CSCEXs) in cancer therapy.Cancer Cell Int. 2024 Oct 5;24(1):334. doi: 10.1186/s12935-024-03514-y. Cancer Cell Int. 2024. PMID: 39369258 Free PMC article. Review.
-
Harnessing exosomes as cancer biomarkers in clinical oncology.Cancer Cell Int. 2024 Aug 7;24(1):278. doi: 10.1186/s12935-024-03464-5. Cancer Cell Int. 2024. PMID: 39113040 Free PMC article. Review.